+499.5%
MRNA vs EMB
+5.7%
+493.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EMB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | 0.0% | -2.3% | -2.4% |
| 7D | +5.5% | 0.0% | +5.5% | +5.2% |
| 30D | +158.7% | -0.3% | +159.0% | +169.4% |
| 3M | +182.1% | -0.4% | +182.5% | +197.0% |
| 6M | +151.8% | +0.1% | +151.7% | +172.7% |
| YTD | +393.6% | +1.6% | +392.0% | +393.9% |
| 1Y | +499.5% | +5.6% | +493.8% | +398.5% |
| All | +499.5% | +5.7% | +493.7% | +398.5% |
Cumulative growth
Daily Returns
Daily percentage return beside EMB.
Daily Out/Under-Performance
Portfolio return minus EMB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EMB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling